The purpose of this project is to evaluate the efficacy of long-acting risperidone for
patients with first episode schizophrenia spectrum who did not improve sufficiently with the
first antipsychotic medication they tried during their initial treatment trial.
Phase:
Phase 4
Details
Lead Sponsor:
Northwell Health
Collaborators:
National Alliance for Research on Schizophrenia and Depression The Zucker Hillside Hospital